Increased chemokines such as CCL2 and CCL20 at mucosal has recently been reported in IBS patients (Hayatbakhsh et al., 2019; Berg et al., 2020; Camilleri et al., 2014). The gene discussed is CCL2; the disease is irritable bowel syndrome.